【药物名称】386/1634, FCE-386/1634
化学结构式(Chemical Structure):
参考文献No.45870
标题:4,5,6,7-Tetrahydroimidazo[4,5-c]pyridine derivatives
作者:Acari, G.; Bernardi, L.; Falconi, G.; Scarponi, U. (Pharmacia Corp.)
来源:BE 0871985; DE 2849572; FR 2433022; GB 2028798; JP 55024158; US 4223146
合成路线图解说明:

The tetahydroimidazopyridine (I) is prepared by condensation of histamine with propionaldehyde in the presence of NaOH. The alkylation in position 1 or 3 is performed with ethyl bromide in a catalytic two-phase system, after protection of the amine group in position 5 as benzyloxycarbonyl derivative, and followed by removal of the protecting group by catalytic hydrogenation. The resulting amines (IVa-b) are then made to react with isopropyl isothiocyanate and the two regioisomers obtained are separated by crystallization.

参考文献No.74450
标题:386/1634
作者:Riva, F.
来源:Drugs Fut 1985,10(2),101
合成路线图解说明:

The tetahydroimidazopyridine (I) is prepared by condensation of histamine with propionaldehyde in the presence of NaOH. The alkylation in position 1 or 3 is performed with ethyl bromide in a catalytic two-phase system, after protection of the amine group in position 5 as benzyloxycarbonyl derivative, and followed by removal of the protecting group by catalytic hydrogenation. The resulting amines (IVa-b) are then made to react with isopropyl isothiocyanate and the two regioisomers obtained are separated by crystallization.

Drug Information Express,Drug R&D,Chemical Database,Patent Search.
Copyright © 2006-2024 Drug Future. All rights reserved.Contact Us